STK11 and cancer: Since STK11 and AMPK have been shown to be involved in the maintenance of redox homeostasis and reactive oxygen species (ROS)-induced cancer cell death, the functioning of the STK11-AMPK pathway may be a negative predictor of response to ROS-induced therapies [85].